Benoxinate 5987-82-6 Ophthalmic Ester Compound Fast Acting Local Numbing Intermediate

Benoxinate (CAS 5987-82-6), also known as oxybuprocaine, is an ester-type compound used in ophthalmic applications. It works by temporarily blocking nerve signal transmission on surface tissues, providing rapid and short-duration local numbing effect.

It is widely used in eye examination procedures and pharmaceutical research due to its fast onset and controlled duration of action.

• Ester type pharmaceutical compound
• Rapid onset of surface numbing effect
• Short duration of activity
• Effective nerve signal inhibition
• Suitable ophthalmic formulation use
• High purity chemical grade
• Stable molecular structure
• Well documented mechanism

• Ophthalmic examination procedures
• Eye surface diagnostic use
• Clinical ophthalmology research
• Pharmaceutical formulation studies
• Local surface numbing research
• Medical intermediate development
• Laboratory pharmacology studies
• Functional compound research

Benoxinate is an ester compound that inhibits sodium ion channel conduction in nerve membranes, resulting in temporary suppression of sensory signal transmission on surface tissues, especially in ophthalmic applications.

• Rapid onset of effect
• Controlled short duration
• Effective surface numbing property
• Stable pharmaceutical structure
• Suitable for ophthalmic research use
• Consistent analytical quality

Store in a sealed container in a cool, dry environment. Avoid light, moisture, and high temperature to maintain stability.

• 1 g / 10 g vials
• 100 g / 500 g sealed bags
• Customized bulk packaging available

Each batch is tested for purity, melting point, solubility, and impurity profile using standardized analytical methods to ensure consistent quality for ophthalmic research application